We therefore analysed in the prospective German Chronic Kidney Disease (GCKD) study whether serum apoA-IV concentrations are associated with a history of cancer as well as incident cancer events in this cohort of CKD patients at high risk for cancer. Here, APOA4 is linked to cancer.